HBW Executive Decisions: HPCUS Service Award For Land; Supplement VP New At CHPA; ACI Adds Microbiology Director; ABC Awards; More
Executive Summary
Mark Land receives HPCUS “Service to Homeopathy Award”; CHPA appoints John Troup to new post of dietary supplements executive; P&G’s Paul Gama elected CHPA board chair; FDA fellow, microbiology expert Queen joins ACI; more executive hires in consumer health and beauty sectors.
You may also be interested in...
CHPA Rebranding Reflects Growing Device Interests In Evolving Self-Care Market
The Consumer Healthcare Products Association’s rebranding initiative – its first in 20 years – aligns the group with today’s self-care marketplace where consumer medical devices play an increasingly prominent role. It also follows “landmark legislative achievements in 2020 that will further empower consumers to practice responsible self-care,” CHPA says.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.